Delivery Order SPE2DB22D3010-SPE2DB25FP3NC
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120 count) with a firm fixed price structure. This non-competitive delivery order, issued on July 21, 2025, is set to be completed by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Lynparza is a specialized oncology medication used in cancer treatment, reflecting DLA's role in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,702.80 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units) under a firm fixed-price contract. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate Office location. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lynparza 150 mg tablets (120 count) valued at $31,702.80. This firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,567.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of 120-count units of Lynparza 150 mg tablets, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Lynparza is a prescription oncology medication used in cancer treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lynparza is a prescription oncology medication, and this delivery represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for the supply of Lynparza (olaparib) 150 mg tablets in quantities of 120 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. The contract was awarded on July 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lynparza...
- The Defense Logistics Agency awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement. The contract was awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $31,558.86 to AmerisourceBergen Drug Corp for 120 tablets of LYNPARZA 100 mg on September 16, 2025, with completion scheduled for October 7, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LYNPARZA is a prescription oncology medication used primarily in cancer treatment, reflecting the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of LYNPARZA 150 mg tablets (60-count units) valued at $5,249.67. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by July 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of LYNPARZA 100 mg tablets (120-count units) with a ceiling value of $10,519.62. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. LYNPARZA is an oncology pharmaceutical used in cancer treatment,...